✦ LIBER ✦

Lysis of tumor cells by the retargeting of murine cytolytic T lymphocytes with bispecific antibodies

✍ Scribed by I. G. Barr; H. R. Macdonald; F. Buchegger; V. Von Fliedner

Publisher: John Wiley and Sons
Year: 1987
Tongue: French
Weight: 652 KB
Volume: 40
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910400323

No coin nor oath required. For personal study only.

✦ Synopsis

The specificity and efficiency of tumor-cell lysis by the retargeting of murine cytolytic lymphocytes (CTL) with bispecific antibodies was examined. Bispecific antibodies (also known as heteroaggregated or hybrid antibodies) were produced by the chemical coupling of monoclonal antibodies (MAbs) against H-2 antigens and the murine T-cell receptor (TCR). Murine tumor cell lines which expressed on their plasma membrane an antigen reactive with one component of the bispecific antibody were efficiently lysed in the presence of polyclonal murine CTL. CTL capable of lysis were generated by stimulating spleen or lymph-node cells with ConA and IL-2, while unstimdated cells or cells incubated only with IL-2 showed no lysis of target cells with bispecific antibodies. Furthermore, the lysis of target cells by bispecific antibodies and CTL did not cause the lysis of bystander cells (cells not expressing an antigen recognized by the antibody which are mixed with the target cells). The efficient CTL-mediated lysis observed with these antibodies makes this a promising approach for the immunotherapy of human cancer.

'To whom reprint requests should be sent.

📜 SIMILAR VOLUMES

Retargeting of T-cell-receptor gamma/del

Retargeting of T-cell-receptor gamma/delta+ lymphocytes against tumor cells by bispecific monoclonal antibodies. Induction of cytolytic activity and lymphokine production

✍ Silvano Ferrini; Ignazia Prigione; Serafina Mammoliti; Maria Ines Colnaghi; Sylv 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 307 KB

We have recently selected MAbs specific for different molecular forms of the TCR gammddelta (expressed by distinct cell subsets), able to activate TCR gamma/delta+ cells. Two of these reagents (GI and Al3) were used for the construction of bispecific MAbs in conjunction with a MAb (Mov 19) directed

The LFA-1/ICAM cell adhesion pathway is

The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes

✍ Silvano Ferrini; Sabrina Sforzini; Anna Cambiaggi; Alessandro Poggi; Raffaella M 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 752 KB

We investigated the role of the LFA-I /ICAM, VLA-4/VCAM-I and CD2/LFAJ adhesion pathways in the cytolysis of tumor cells mediated by an anti-EGF-R/anti-CD3 bispecific monoclonal antibody (biMAb). The biMAb induced efficient lysis of

Studies on the nature of the cell surfac

Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirusinduced tumors

✍ Elisabeth Gomard; J. P. Levy; F. Plata; Yvette Henin; Véronique Duprez; A. Bismu 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 899 KB

Bispecific antibodies reactive with the

Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cells

✍ J. van Dijk; T. Tsuruo; D. M. Segal; R. L. H. Bolhuis; R. Colognola; R. J. van d 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 620 KB

## We describe the lysis of multidrug-resistant (MDR) tumor cells by various lymphocytic effector cells, retargeted with bispecific antibodies (heteroconjugates). The Ab -heteroconjugate used was prepared by chemically cross-linking the OKT3 monoclonal antibody (MAb) reactive with CD3 antigen on T

Targeting of T lymphocytes against egf-r

Targeting of T lymphocytes against egf-receptor+ tumor cells by bispecific monoclonal antibodies: Requirement of CD3 molecule cross-linking for t-cell activation

✍ Silvano Ferrini; Anna Cambiaggi; Sabrina Sforzini; Sabrina Marciano; Silvana Can 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 835 KB

Serial killing of tumor cells by cytotox

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct

✍ Patrick Hoffmann; Robert Hofmeister; Klaus Brischwein; Christian Brandl; Sandrin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 359 KB

## Abstract Certain bispecific antibodies exhibit an extraordinary potency and efficacy for target cell lysis by eliciting a polyclonal T‐cell response. One example is a CD19‐/CD3‐bispecific single‐chain antibody construct (bscCD19xCD3), which at femtomolar concentrations can redirect cytotoxic T c